Ovid Therapeutics
OVID
OVID
59 hedge funds and large institutions have $65.5M invested in Ovid Therapeutics in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
12% less capital invested
Capital invested by funds: $74.5M → $65.5M (-$8.99M)
Holders
59
Holding in Top 10
–
Calls
$52K
Puts
–
Top Buyers
| 1 | +$3.01M | |
| 2 | +$2.56M | |
| 3 | +$370K | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$160K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$83.7K |
Top Sellers
| 1 | -$3.58M | |
| 2 | -$364K | |
| 3 | -$224K | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$174K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$138K |